ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Enzene Biosciences Ltd. obtains Marketing Authorization for its Romiplostim Biosimilar drug in India
August 26, 2021Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug "Romiplostim", indicated for the treatment of chronic Immune Thrombocytopenic Purpura.
Pharma Sources Insight January 2025
